What is CBG?
How does it arise
CBG is classed as a non-psychoactive cannabinoid, meaning it is not intoxicating, which makes it different from THC. As it is only present in small amounts (usually less than 1%) in most cannabis varieties, CBG is considered a minor cannabinoid. Surprisingly, however, the two most important and abundant cannabinoids - THC and CBD - come from CBG. The latter is their chemical precursor (the substance that takes part in the chemical reaction that produces another substance).
Cannabis plants first produce cannabigerol acid (CBGA) during their life cycle - which is the precursor of the three main subgroups of cannabinoids: tetrahydrocannabinolic acid (THCA), cannabidiol acid (CBDA) and cannabichromenoic acid (CBCA).
Image: CBGA is the chemical precursor of THCA, CBDA and CBCA (not shown). Enzymes found in cannabis convert CBGA into either THCA or CBDA, which then undergo decarboxylation ('activation') by light or heat energy, resulting in the well-known cannabinoids THC or CBD.
Specific enzymes in the plant break down CBGA and "direct" it to one of three subgroups. These acids are exposed to ultraviolet light or heat energy and voila, they become the known cannabinoids - THC and CBD. In most varieties, CBGA is immediately converted to either THCA or CBDA. So more THC means less CBG and CBD (and vice versa).
Today, breeders are experimenting with genetic manipulation and crossbreeding to increase the amount of CBG. The seed bank Subcool Seeds, for example, crosses varieties to create plants with higher CBG content. Scientists can also extract a higher percentage of CBG from germinating plants by determining the optimal extraction time, which is approximately six weeks during the total eight-week flowering phase. This is how the Dutch company Bedrocan produces its official medicinal variety Bediol.
Possible health benefits of CBG
The endocannabinoid system is a receptor system found throughout the human body that maintains it in a state of homeostasis. While there are some specific details about how cannabinoids interact with the endocannabinoid system, in general they can affect diametrically opposed functions specific to each area of the body. For example, when there is an injury, the endocannabinoid system helps to regulate the cells of the immune system, thereby reducing inflammation.
CBG has been found to act on very specific physiological systems and problems and its medical use is showing promise, although more clinical research on human patients is obviously needed.
Here is a summary of what we know today:
- CBG could be particularly effective in treating glaucoma because it reduces intraocular pressure. It is a potent vasodilator that also has neuroprotective effects.
- In experiments on animals, specifically mice, CBG was found to effectively reduce the inflammation characteristic of inflammatory bowel disease.
- In a 2015 study, neurons in mice suffering from Huntington's disease, which is characterised by degeneration of nerve cells in the brain, were shown to be protected by CBG.
- CBG is also proving to be a promising cancer fighter. As a concrete example, cannabigerol inhibits the receptors that cause cancer cells to grow. In one animal study, it was shown to inhibit the growth of cancer cells in the colon and rectum in mice, slowing the progression of colon cancer. CBG inhibits tumours and chemically induced carcinogenesis, thus offering a very interesting option for the treatment of colorectal cancer.
- Research suggests that CBG could also be an effective antibacterial agent, particularly against methicillin-resistant golden staphylococcus aureus (MRSA), which is resistant to various classes of drugs.
- In a recent 2017 study, researchers claim that purified CBG stimulates appetite in rats. This could lead to an unusual non-psychotropic treatment for cachexia, which is muscle wasting and significant weight loss in late-stage cancer and other diseases due to inadequate food intake.
- In a study looking at the effects of five different cannabinoids on overactive bladder syndrome, CBG performed best in inhibiting muscle contractions, so it could play an important role in preventing bladder dysfunction in the future.
Scientists are pleasantly surprised by these initial results with CBG and are promoting future research with CBG alone (isolated) or with CBG in combination with other cannabinoids (due to the so-called synergistic effect) for the treatment of various diseases. As it is a non-psychotropic substance, CBG has a wide range of potential uses not only for the above mentioned problems, but also for its analgesic effects, treatment of psoriasis and as an antidepressant.
PHOTO: iStock
"All information contained on this website, as well as information provided through this website, is for educational purposes only. None of the information contained herein is intended as a substitute for medical diagnosis and such information is not to be considered medical advice or recommended treatment. This website does not promote, endorse or advocate the legal or illegal use of narcotic drugs or psychotropic substances or the commission of any other illegal activity. Please see our Disclaimer for further information."